Butyrylcholinesterase and α-amylase are essential targets for drugs and extracts because their inhibition is involved in the management of Alzheimer’s disease (AD) and diabetes mellitus (DM) [13,14]. This evidence concerns the gene BCHE and Alzheimer disease.